533 related articles for article (PubMed ID: 15514571)
21. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
22. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
23. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
24. Drug-eluting stents: clinical experiences and perspectives.
Grube E; Gerckens U; Buellesfeld L
Minerva Cardioangiol; 2002 Oct; 50(5):469-73. PubMed ID: 12384629
[TBL] [Abstract][Full Text] [Related]
25. Comparison of bare-metal and sirolimus- or paclitaxel-eluting stents for aorto-ostial coronary disease.
Barlis P; Kaplan S; Dimopoulos K; Ferrante G; Di Mario C
Cardiology; 2008; 111(4):270-6. PubMed ID: 18451644
[TBL] [Abstract][Full Text] [Related]
26. Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
[TBL] [Abstract][Full Text] [Related]
27. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent.
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stents: the panacea for restenosis?
Lim MC
Singapore Med J; 2004 Jul; 45(7):300-2. PubMed ID: 15221043
[No Abstract] [Full Text] [Related]
29. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials.
Halkin A; Stone GW
J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330
[TBL] [Abstract][Full Text] [Related]
30. Comparative clinical outcomes of paclitaxel- and sirolimus-eluting stents: results from a large prospective multicenter registry--STENT Group.
Simonton CA; Brodie B; Cheek B; Krainin F; Metzger C; Hermiller J; Juk S; Duffy P; Humphrey A; Nussbaum M; Laurent S;
J Am Coll Cardiol; 2007 Sep; 50(13):1214-22. PubMed ID: 17888837
[TBL] [Abstract][Full Text] [Related]
31. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS
Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063
[TBL] [Abstract][Full Text] [Related]
32. Through the drug-eluting stent labyrinth.
Guagliumi G; Musumeci G; Vassileva A; Tespili M; Valsecchi O
Ital Heart J; 2003 Apr; 4(4):236-45. PubMed ID: 12784776
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents].
de la Torre Hernández JM; Sainz Laso F; Ruisánchez C; Zueco J; Figueroa A; Colman T
Rev Esp Cardiol; 2005 Mar; 58(3):262-9. PubMed ID: 15766448
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
35. The paclitaxel-eluting stent in percutaneous coronary intervention: part I: background and clinical comparison to bare metal stents.
Gruchalla KJ; Nawarskas JJ
Cardiol Rev; 2006; 14(2):88-98. PubMed ID: 16493246
[TBL] [Abstract][Full Text] [Related]
36. Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.
Chong PH; Cheng JW
Ann Pharmacother; 2004 May; 38(5):845-52. PubMed ID: 15039482
[TBL] [Abstract][Full Text] [Related]
37. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
Gil RJ
Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
[No Abstract] [Full Text] [Related]
38. Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions.
Chieffo A; Colombo A
Herz; 2004 Mar; 29(2):147-51. PubMed ID: 15054587
[TBL] [Abstract][Full Text] [Related]
39. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
[TBL] [Abstract][Full Text] [Related]
40. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]